Literature DB >> 25060055

The biomarker niche for fibroblast growth factor 23 testing in CKD.

Myles Wolf1.   

Abstract

Entities:  

Keywords:  CKD; ESRD; FGF-23

Mesh:

Substances:

Year:  2014        PMID: 25060055      PMCID: PMC4279750          DOI: 10.1681/ASN.2014060621

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  15 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

2.  Serum fibroblast growth factor-23 is associated with incident kidney disease.

Authors:  Casey M Rebholz; Morgan E Grams; Josef Coresh; Elizabeth Selvin; Lesley A Inker; Andrew S Levey; Paul L Kimmel; Ramachandran S Vasan; John H Eckfeldt; Harold I Feldman; Chi-Yuan Hsu; Pamela L Lutsey
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

3.  Fibroblast growth factor-23 and cardiovascular events in CKD.

Authors:  Julia J Scialla; Huiliang Xie; Mahboob Rahman; Amanda Hyre Anderson; Tamara Isakova; Akinlolu Ojo; Xiaoming Zhang; Lisa Nessel; Takayuki Hamano; Juan E Grunwald; Dominic S Raj; Wei Yang; Jiang He; James P Lash; Alan S Go; John W Kusek; Harold Feldman; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

4.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

5.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  Mineral metabolites and CKD progression in African Americans.

Authors:  Julia J Scialla; Brad C Astor; Tamara Isakova; Huiliang Xie; Lawrence J Appel; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 10.121

7.  FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells.

Authors:  Yu-Hsun Kao; Yao-Chang Chen; Yung-Kuo Lin; Rong-Jie Shiu; Tze-Fan Chao; Shih-Ann Chen; Yi-Jen Chen
Journal:  Eur J Clin Invest       Date:  2014-08       Impact factor: 4.686

8.  Renal toxicity of phosphate in rats.

Authors:  L L Haut; A C Alfrey; S Guggenheim; B Buddington; N Schrier
Journal:  Kidney Int       Date:  1980-06       Impact factor: 10.612

9.  Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Robert H Hopkins; Donna E Sweet; Melissa Starkey; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-12-17       Impact factor: 25.391

Review 10.  Update on fibroblast growth factor 23 in chronic kidney disease.

Authors:  Myles Wolf
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

View more
  3 in total

1.  FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation.

Authors:  Xiaomin Zhang; Kaiwen Guo; Feng Xia; Xinyu Zhao; Zhifeng Huang; Jianlou Niu
Journal:  BMC Biotechnol       Date:  2018-05-30       Impact factor: 2.563

2.  Bone-Derived Extracellular Vesicles: Novel Players of Interorgan Crosstalk.

Authors:  Yi Li; Pengbin Yin; Zhongkui Guo; Houchen Lv; Yuan Deng; Ming Chen; Ya Gu; Peifu Tang; Licheng Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

3.  Urinary phosphate-containing nanoparticle contributes to inflammation and kidney injury in a salt-sensitive hypertension rat model.

Authors:  Qin Wang; Kenichi Ishizawa; Jinping Li; Wataru Fujii; Yoshikazu Nemoto; Osamu Yamazaki; Yoshifuru Tamura; Yutaka Miura; Xuedan Nie; Ryo Abe; Hiroko Segawa; Makoto Kuro-O; Shigeru Shibata
Journal:  Commun Biol       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.